Literature DB >> 26983630

Diuretics in the treatment of hypertension.

Douglas L Blowey1.   

Abstract

Diuretics have long been used for the treatment of hypertension. Thiazide diuretics are the most commonly prescribed diuretics for hypertension, but other classes of diuretics may be useful in alternative circumstances. Although diuretics are no longer considered the preferred agent for treatment of hypertension in adults and children, they remain acceptable first-line options. Diuretics effectively decrease blood pressure in hypertensive patients, and in adults with hypertension reduce the risk of adverse cardiovascular outcomes. Because of varied pharmacokinetic and pharmacodynamic differences, chlorthalidone may be the preferred thiazide diuretic in the treatment of primary hypertension. Other types of diuretics (e.g., loop, potassium sparing) may be useful for the treatment of hypertension related to chronic kidney disease (CKD) and other varied conditions. Common side effects of thiazides are mostly dose-related and involve electrolyte and metabolic abnormalities.

Entities:  

Keywords:  Children; Chlorthalidone; Diuretics; Hydrochlorothiazide; Hypertension; Thiazide diuretic

Mesh:

Substances:

Year:  2016        PMID: 26983630     DOI: 10.1007/s00467-016-3334-4

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  59 in total

1.  Relationship between plasma and extracellular fluid volume depletion and the antihypertensive effect of chlorothiazide.

Authors:  I M WILSON; E D FREIS
Journal:  Circulation       Date:  1959-12       Impact factor: 29.690

Review 2.  Familial hyperkalemic hypertension.

Authors:  Juliette Hadchouel; Céline Delaloy; Sébastien Fauré; Jean-Michel Achard; Xavier Jeunemaitre
Journal:  J Am Soc Nephrol       Date:  2005-10-12       Impact factor: 10.121

3.  WNK1 kinase polymorphism and blood pressure response to a thiazide diuretic.

Authors:  Stephen T Turner; Gary L Schwartz; Arlene B Chapman; Eric Boerwinkle
Journal:  Hypertension       Date:  2005-09-19       Impact factor: 10.190

Review 4.  Diuretics in the treatment of hypertension. Part 1: thiazide and thiazide-like diuretics.

Authors:  Juan Tamargo; Julian Segura; Luis M Ruilope
Journal:  Expert Opin Pharmacother       Date:  2014-01-20       Impact factor: 3.889

Review 5.  Blood pressure-lowering efficacy of monotherapy with thiazide diuretics for primary hypertension.

Authors:  Vijaya M Musini; Mark Nazer; Ken Bassett; James M Wright
Journal:  Cochrane Database Syst Rev       Date:  2014-05-29

6.  Meta-analysis of dose-response relationships for hydrochlorothiazide, chlorthalidone, and bendroflumethiazide on blood pressure, serum potassium, and urate.

Authors:  Mark A Peterzan; Rebecca Hardy; Nish Chaturvedi; Alun D Hughes
Journal:  Hypertension       Date:  2012-04-30       Impact factor: 10.190

7.  Chlorthalidone reduces cardiovascular events compared with hydrochlorothiazide: a retrospective cohort analysis.

Authors:  Michael P Dorsch; Brenda W Gillespie; Steven R Erickson; Barry E Bleske; Alan B Weder
Journal:  Hypertension       Date:  2011-03-07       Impact factor: 10.190

8.  Beta-blocker/thiazide combination for treatment of hypertensive children: a randomized double-blind, placebo-controlled trial.

Authors:  Jonathan M Sorof; Paul Cargo; Jay Graepel; David Humphrey; Eileen King; Clyde Rolf; Robert J Cunningham
Journal:  Pediatr Nephrol       Date:  2002-05       Impact factor: 3.714

9.  2003 World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertension.

Authors:  Judith A Whitworth
Journal:  J Hypertens       Date:  2003-11       Impact factor: 4.844

10.  Are thiazide diuretics safe and effective antihypertensive therapy in kidney transplant recipients?

Authors:  David J Taber; Titte M Srinivas; Nicole A Pilch; Holly B Meadows; James N Fleming; John W McGillicuddy; Charles F Bratton; Beje Thomas; Kenneth D Chavin; Prabhakar K Baliga; Leonard E Egede
Journal:  Am J Nephrol       Date:  2013-09-21       Impact factor: 3.754

View more
  8 in total

1.  Diuretic effect of extracts, fractions and two compounds 2α,3β,19α-trihydroxy-urs-12-en-28-oic acid and 5-hydroxy-3,6,7,8,4'-pentamethoxyflavone from Rubus rosaefolius Sm. (Rosaceae) leaves in rats.

Authors:  Priscila de Souza; Thaise Boeing; Lincon Bordignon Somensi; Camile Cecconi Cechinel-Zanchett; Jairo Kenupp Bastos; Marcel Petreanu; Rivaldo Niero; Valdir Cechinel-Filho; Luisa Mota da Silva; Sérgio Faloni de Andrade
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2016-12-24       Impact factor: 3.000

Review 2.  Antihypertensives in Children and Adolescents.

Authors:  Craig Authement; Joshua Samuels; Joyce P Samuel
Journal:  Curr Hypertens Rep       Date:  2022-09-17       Impact factor: 4.592

Review 3.  Fibroblast growth factor 23-Klotho and hypertension: experimental and clinical mechanisms.

Authors:  Michael Freundlich; Gerardo Gamba; Bernardo Rodriguez-Iturbe
Journal:  Pediatr Nephrol       Date:  2020-11-23       Impact factor: 3.714

Review 4.  The Pharmacological Treatment of Pediatric Vertigo.

Authors:  Pasquale Viola; Gianmarco Marcianò; Alessandro Casarella; Davide Pisani; Alessia Astorina; Alfonso Scarpa; Elena Siccardi; Emanuele Basile; Giovambattista De Sarro; Luca Gallelli; Giuseppe Chiarella
Journal:  Children (Basel)       Date:  2022-04-20

Review 5.  Hypertension in pediatric patients with chronic kidney disease: management challenges.

Authors:  Claire M Gallibois; Natasha A Jawa; Damien G Noone
Journal:  Int J Nephrol Renovasc Dis       Date:  2017-07-26

Review 6.  Review of Clinical Trials on the Effects of Tai Chi Practice on Primary Hypertension: The Current State of Study Design and Quality Control.

Authors:  Yuke Teng; Sha Yang; Yuan Chen; Yuyi Guo; Yushi Hu; Pan Zhang; Jingya Cao; Xinyue Zhang; Yalan Chen; Caili Jiang; Tianyu Liu; Fang Zeng
Journal:  Evid Based Complement Alternat Med       Date:  2020-12-30       Impact factor: 2.629

Review 7.  Molecular Basis, Diagnostic Challenges and Therapeutic Approaches of Bartter and Gitelman Syndromes: A Primer for Clinicians.

Authors:  Laura Nuñez-Gonzalez; Noa Carrera; Miguel A Garcia-Gonzalez
Journal:  Int J Mol Sci       Date:  2021-10-22       Impact factor: 5.923

8.  Network Pharmacology and Molecular Docking Combined to Analyze the Molecular and Pharmacological Mechanism of Pinellia ternata in the Treatment of Hypertension.

Authors:  Zhaowei Zhai; Xinru Tao; Mohammad Murtaza Alami; Shaohua Shu; Xuekui Wang
Journal:  Curr Issues Mol Biol       Date:  2021-05-01       Impact factor: 2.976

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.